Waters Corporation (N:WAT)

Business Focus: Advanced Medical Equipment & Technology

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for WAT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 28th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 27/20 Feb 26/20 Kim Francis Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -1,471  
Feb 27/20 Feb 26/20 Kim Francis Direct Ownership Common Stock S - Open market or private sale -1,471 $207.33
Feb 27/20 Feb 26/20 Kim Francis Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,471 $154.33
Feb 27/20 Feb 25/20 Aleman Keeley A Indirect Ownership Common Stock J - Other transaction 78  
Feb 27/20 Feb 25/20 Silveira Michael F Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 4,124  
Feb 25/20 Feb 21/20 Salice Thomas P Direct Ownership Common Stock J - Other transaction 9,374  
Feb 25/20 Feb 21/20 Salice Thomas P Indirect Ownership Common Stock J - Other transaction -9,374  
Feb 24/20 Feb 21/20 Aleman Keeley A Indirect Ownership Common Stock S - Open market or private sale -36 $216.75
Feb 24/20 Feb 21/20 Aleman Keeley A Direct Ownership Common Stock S - Open market or private sale -115 $216.79
Feb 19/20 Feb 18/20 Aleman Keeley A Indirect Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -6  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for WAT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET February 28th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Feb 27/20 Feb 25/20 Aleman Keeley A Indirect Ownership Common Stock J - Other transaction 78  
Feb 27/20 Feb 25/20 Silveira Michael F Direct Ownership Stock Option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 4,124  
Feb 27/20 Feb 26/20 Kim Francis Direct Ownership Stock Option (Right to Buy) M - Exercise or conversion exempt under rule 16b-3 -1,471  
Feb 27/20 Feb 26/20 Kim Francis Direct Ownership Common Stock S - Open market or private sale -1,471 $207.33
Feb 27/20 Feb 26/20 Kim Francis Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,471 $154.33
Feb 25/20 Feb 21/20 Salice Thomas P Direct Ownership Common Stock J - Other transaction 9,374  
Feb 25/20 Feb 21/20 Salice Thomas P Indirect Ownership Common Stock J - Other transaction -9,374  
Feb 24/20 Feb 21/20 Aleman Keeley A Indirect Ownership Common Stock S - Open market or private sale -36 $216.75
Feb 24/20 Feb 21/20 Aleman Keeley A Direct Ownership Common Stock S - Open market or private sale -115 $216.79
Feb 19/20 Feb 18/20 Aleman Keeley A Indirect Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -6  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $WAT

Competitors

Competitors with Recent Insider Filings
Edwards Lifesciences (N:EW)
Intuitive Surgical (OQ:ISRG)
Danaher (N:DHR)